CD4 and COVID-19: Detection of SARS-CoV-2 cross-reactive CD8 and particularly CD4 T cells, probably elicited by endemic common cold causing coronaviruses, in 40–81% of unexposed individuals may contribute to the relative protection of most people against COVID-19 (16, 19, 29, 30, 37, 40).